Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.42 USD | +2.06% | +11.38% | +29.54% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.54% | 534M | |
-2.47% | 88.14B | |
+1.45% | 40.44B | |
-14.43% | 32.24B | |
+52.98% | 24.39B | |
-14.85% | 15.59B | |
-13.87% | 12.14B | |
-7.87% | 12.18B | |
-39.40% | 12.3B | |
+4.19% | 8.87B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- RBC Cuts Price Target on Avid Bioservices to $22 From $32, Citing Lower Group Multiples, Maintains Outperform Rating